Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6528961rdf:typepubmed:Citationlld:pubmed
pubmed-article:6528961lifeskim:mentionsumls-concept:C2917212lld:lifeskim
pubmed-article:6528961lifeskim:mentionsumls-concept:C0427611lld:lifeskim
pubmed-article:6528961lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:6528961lifeskim:mentionsumls-concept:C0015354lld:lifeskim
pubmed-article:6528961lifeskim:mentionsumls-concept:C0205374lld:lifeskim
pubmed-article:6528961pubmed:issue12lld:pubmed
pubmed-article:6528961pubmed:dateCreated1985-3-28lld:pubmed
pubmed-article:6528961pubmed:abstractTextThe customary use of standardized regimens for heparin anticoagulation and its neutralization by protamine in cardiopulmonary bypass may result in gross over- or underdosage of either substance with resulting clinical problems. Heparin and protamine doses, postoperative blood loss during the first 20 h and the need for bank blood in a group of 100 patients following a fixed heparin-protamine protocol were compared with another group of 106 cases with ACT-guided heparin and protamine dosage. In the ACT-group the mean heparin dose was 22.5% less (3.57 mg/kg and 4.60 mg/kg respectively) than in the standard group. Protamine doses fell by 58.5% from 5.11 mg/kg to 2.12 mg/kg in the ACT-group. The mean postoperative blood loss in the ACT-cases was 4.54 ml/kg/20h, 2.29 ml respectively 33.5% less than that of control group. The demand for bank blood in the ACT-group was 1.97 units opposed to 5.12 units in the standardized regimen group.lld:pubmed
pubmed-article:6528961pubmed:languagegerlld:pubmed
pubmed-article:6528961pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6528961pubmed:citationSubsetIMlld:pubmed
pubmed-article:6528961pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6528961pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6528961pubmed:statusMEDLINElld:pubmed
pubmed-article:6528961pubmed:monthDeclld:pubmed
pubmed-article:6528961pubmed:issn0003-2417lld:pubmed
pubmed-article:6528961pubmed:authorpubmed-author:KesslerGGlld:pubmed
pubmed-article:6528961pubmed:authorpubmed-author:GrünesGGlld:pubmed
pubmed-article:6528961pubmed:issnTypePrintlld:pubmed
pubmed-article:6528961pubmed:volume33lld:pubmed
pubmed-article:6528961pubmed:ownerNLMlld:pubmed
pubmed-article:6528961pubmed:authorsCompleteYlld:pubmed
pubmed-article:6528961pubmed:pagination588-91lld:pubmed
pubmed-article:6528961pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:meshHeadingpubmed-meshheading:6528961-...lld:pubmed
pubmed-article:6528961pubmed:year1984lld:pubmed
pubmed-article:6528961pubmed:articleTitle[Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].lld:pubmed
pubmed-article:6528961pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6528961pubmed:publicationTypeEnglish Abstractlld:pubmed